옵션 체인은 다양한 행사가격과 만기일에 대한 Humacyte의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Humacyte에 대한 시장 심리를 평가합니다..

Humacyte (NASDAQ:HUMA) 주식, 옵션 체인

Humacyte

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Senator Tommy Tuberville

News

Politics

Personal Finance

ARKK

HUMA

INTC

PARA

PARAA

SOLV

SSBK

미국 의회 의원들의 주식 거래 활동은 위원회 임무를 포함한 이해 상충이 거래에 영향을 미칠 수 있다는 가능성으로 인해 투자자들로부터 지속적으로 관심을 끌고 있다. 잘 알려진 한 의회 의원은 금요일 시장 마감 무렵에 여러 거래를 공개했다.

미 상원 의원 토미 튜버빌은 여러 대형주의 매도와 매수 포지션 공개

Humacyte Inc

HUMAN PHEROMONE SCIENCE by Human Pheromone Sciences, Inc.

Human - United States Dollar

HUMAN HOLDINGS CO LTD by Human Holdings Co., Ltd.

Human Holdings Co Ltd

HUMAN UNITEC INTL INC by Human Unitec International, Inc.

Human Unitec International Inc

Humana Inc

Humanigen Inc

Humankind US Stock ETF

Humanscape

Humatech Inc

Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) has outperformed the market over the past 15 years by 6.65% on an annualized basis producing an average annual return of 17.74%. Currently, Applied Mat has a market capitalization of $119.65 billion. 
Buying $100 In AMAT: If an investor had bought $100 of AMAT stock 15 years ago, it would be worth $1,113.62 today based on a price of $147.22 for AMAT at the time of writing.
<h3>Applied Mat's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746026112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

AMAT

$100 Invested In Applied Mat 15 Years Ago Would Be Worth This Much Today

WIIM

Scotts Miracle-Gro shares are trading lower following a Q2 sales miss.

DT Midstream shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.

Goldman Sachs analyst Christine Cho downgrades Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) from Buy to Neutral and lowers the price target from $103 to $85.

Downgrades

Price Target

Analyst Ratings

SBUX

Goldman Sachs Downgrades Starbucks to Neutral, Lowers Price Target to $85

Schlumberger shares are trading lower after Piper Sandler cut its price target on the stock from $46 to $44.

Barclays analyst Matt Miksic maintains InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) with a Overweight and lowers the price target from $29 to $24.

INMD

Barclays Maintains Overweight on InMode, Lowers Price Target to $24

NTRA

Natera shares are trading lower. The company reported results from its DEFINE-HT clinical trial.

HUM stock has given up its prior gain. Humana shares were trading higher after the company reported better-than-expected Q1 adjusted EPS results.

Public Service Enterprise shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.

Barclays analyst Julian Mitchell maintains Honeywell Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>) with a Overweight and lowers the price target from $247 to $243.

Barclays Maintains Overweight on Honeywell Intl, Lowers Price Target to $243

Starbucks Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) shares are facing heavy selling pressure Wednesday morning after the company reported worse-than-expected results <a href="https://www.benzinga.com/news/earnings/25/04/45084597/starbucks-misses-q2-earnings-estimates-ceo-says-optimism-has-turned-into-confidence-i-see-more-opportunity-than-i-imagined">for the second quarter</a>. 
<ul>
<li>Q2 Revenue: $8.76 billion, versus <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">estimates</a>&nbsp;of $8.86 billion</li>
</ul>
<ul>
<li>Q2 Adjusted EPS: 41 cents, versus estimates of 50 cents</li>
</ul>
Second-quarter net revenue climbed 2% on a year-over-year basis, but global comparable store sales fell 1%, driven by a 2%&nbsp;decline in comparable transactions. 
Comparable store sales were down 1% in North America and down 2% internationally. Starbucks noted that comparable store sales in China were flat in the quarter.
The coffee giant opened 213 net new stores in&nbsp;the quarter and had 40,789 total locations at quarter&#8217;s end.
Despite the soft headline numbers, CEO Brian Niccol provided optimistic commentary that turnaround plans are on track.
"My optimism has turned into confidence that our ‘Back to Starbucks' plan is the right strategy to turn the business around and to unlock opportunities ahead,"&nbsp;Niccol said.
"Improving transaction comp in a tough consumer environment at our scale is a testament to the power of our brand and partners getting ‘Back to Starbucks.' We are on track and if anything, I see more opportunity than I imagined.&#8221;
Check This Out: <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/45100047/recession-odds-spike-wall-street-tumbles-as-q1-gdp-surprisingly-contracts-be-patient-trump-responds">Recession Odds Spike, Wall Street Tumbles As Q1 GDP Surprisingly Contracts: &#8216;Be Patient,&#8217; Trump Responds</a>
Analysts don&#8217;t appear to be quite so optimistic, with some cutting estimates in response to the company&#8217;s weak quarterly results.
TD Securities analyst Agnes Lim maintained Starbucks with a <a href="https://www.benzinga.com/analyst-stock-ratings">Buy rating</a>, but lowered the price target from&nbsp;$102&nbsp;to&nbsp;$90. Guggenheim analyst Gregory Francfort also cut estimates on Starbucks this week, citing <a href="https://www.benzinga.com/trading-ideas/movers/25/04/45087119/analyst-warns-starbucks-faces-growing-risks-from-competition-costs-and-global-tensions">rising competition</a> from local brands and potential impacts from ongoing global trade tensions.
In an interview on CNBC&#8217;s &#8220;Squawk On The Street&#8221; Wednesday morning, Niccol reinforced the company&#8217;s turnaround plans and said a lot of the progress is happening &#8220;below the surface.&#8221;
&#8220;We&#8217;re taking a stage gate approach, where we&#8217;re going to first learn on it and then we&#8217;ll roll and scale it,&#8221; Niccol said. 
The Starbucks CEO said the company is seeing a &#8220;great response&#8221; from customers where it&#8217;s testing some of its &#8220;Back to Starbucks&#8221; initiatives.
Other changes on the horizon include a revamp of the digital experience and an overhaul of the company&#8217;s rewards program, which had been acting more like a &#8220;coupon book&#8221; in the past, he said.
&#8220;In the near-term, the earnings will lag, but in the longer-term, my experience always has been, if you drive growth and do the right thing for the customer, our partner, the financial performance comes with it,&#8221; Niccol told CNBC.
SBUX Price Action: <a href="https://www.benzinga.com/quote/SBUX" target="_blank" rel="noreferrer noopener">Starbucks shares</a> were down 7.51% at $78.45 at the time of publication Wednesday, according to <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/04/45097966/starbucks-posts-weak-earnings-joins-super-micro-computer-snap-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session">Starbucks Posts Weak Earnings, Joins Super Micro Computer, Snap And Other Big Stocks Moving Lower</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/Ned+Snowman">Ned Snowman</a>/Shutterstock.

Earnings

Movers

Starbucks Stock Tumbles On Q2 Earnings, CEO Says Progress Is Happening 'Below The Surface'

Vulcan Materials shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

Floki (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">FLOKI</a>) is up 7% in the past 24 hours and 23% over the past 30 days, showing notable relative strength, with traders and analysts pointing to bullish momentum, fresh utility and <a href="https://www.benzinga.com/money/floki-price-prediction">key partnerships as drivers</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Floki (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">FLOKI</a>)</td>
<td>&nbsp;$0.00008707</td>
<td>$836.3 million</td>
<td>+4.3%&nbsp;</td>
<td>&nbsp;+23.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1700</td>
<td>$25.3 billion</td>
<td>-4.8%&nbsp;</td>
<td>&nbsp;-6.8%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001293</td>
<td>$7.6 billion</td>
<td>-4.9%&nbsp;</td>
<td>-4.9%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Posty noted price action is "playing out almost perfectly," saying it's the only top 10 meme coin in the green on Wednesday.
 Analyst CRG flagged that Floki is holding above the daily cloud, showing continued bullish strength.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24FLOKI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FLOKI</a> now firmly above the daily cloud Best performer of the top 100 today Beauty <a href="https://t.co/1aUYa21m0x">https://t.co/1aUYa21m0x</a> <a href="https://t.co/XXahXTdify">pic.twitter.com/XXahXTdify</a>
&mdash; CRG (@MacroCRG) <a href="https://twitter.com/MacroCRG/status/1917508012060627166?ref_src=twsrc%5Etfw">April 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Glauber Contessoto <a href="https://x.com/ProTheDoge/status/1917471006953725996">outlined</a> five factors behind Floki&#8217;s staying power, saying it is the only meme coin besides DOGE with its own ETP, survived multiple cycles like DOGE and SHIB. 
It is also the largest meme coin on Binance Smart Chain and the only meme coin to break all-time highs. 
Trader Unipcs called Floki's resilience "interesting," highlighting its relative strength compared to peers.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">interesting relative strength from <a href="https://twitter.com/search?q=%24FLOKI&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$FLOKI</a> recently &#x1f440; <a href="https://t.co/j7LmiKlWXj">https://t.co/j7LmiKlWXj</a> <a href="https://t.co/VtDuaNv5dQ">pic.twitter.com/VtDuaNv5dQ</a>
&mdash; Unipcs (aka &#39;Bonk Guy&#39;) &#x1f392; (@theunipcs) <a href="https://twitter.com/theunipcs/status/1917507180741394704?ref_src=twsrc%5Etfw">April 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Statistics: IntoTheBlock data shows an increase of 5% in large transaction volume and transactions greater than $100,000 increased from 15 to 16. Around 53% Floki holders are making profit at current levels.
Coinglass data shows Floki open interest decreased 1.8% while derivatives trading volume narrowed by 25.6%.
Community News: In an X <a href="https://x.com/RealFlokiInu/status/1916913017972834771">post</a> on April 28, Floki recently unveiled a partnership with Rice Robotics, announcing the upcoming launch of an AI-powered companion robot, the FLOKI minibot M1. 
The robot will be natively integrated with Rice's decentralized RICE AI protocol, marking another utility-backed milestone for the Floki ecosystem.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/45030998/dogecoin-millionaire-says-give-a-serious-thought-to-floki-as-memecoin-makes-impressive-30-gains-over-7-days-asks-followers-to-strap-in">Dogecoin &#8216;Millionaire&#8217; Says Give A &#8216;Serious&#8217; Thought To Floki As Memecoin Makes Impressive 30% Gains Over 7 Days, Asks Followers To &#8216;Strap In&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$FLOKI

$SHIB

Floki Jumps 23% In 7 Days: What's Powering The Relative Strength Against Dogecoin, Shiba Inu?

ZBRA

Zebra Technologies shares are trading lower after UBS cut its price target on the stock from $425 to $410 and Needham cut its price target from $395 to $325.

-&nbsp; &nbsp;Vuzix optics to power AR wearables that fuse visible and infrared light—enabling users to see in the dark, detect heat signatures, and visualize temperature changes in real time
ROCHESTER, N.Y., April 30, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4417075-1&amp;h=3926056526&amp;u=http%3A%2F%2Fwww.vuzix.com%2Fhome%2F&amp;a=Vuzix%C2%AE+Corporation">Vuzix&#xAE; Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>), ("Vuzix" or the "Company"), a leading supplier of smart glasses, waveguides, and augmented reality (AR) technologies, today announced it has received a six-figure dollar order for custom color waveguides with a 30-degree field of view (FOV). The Vuzix-designed and manufactured waveguides will be integrated into a new generation of thermal smart glasses being developed in collaboration with a European design and R&amp;D advisory firm. This production order is after a nearly two-year development cycle with Vuzix and the customer. The customer expects that volume production of the smart glasses is expected to begin in fall 2025, led by one of the world's largest contract electronics manufacturers.

Contracts

VUZI

Vuzix Has Received A Six-figure Dollar Order For Custom Color Waveguides With A 30-degree Field Of View; Expects That Volume Production Of The Smart Glasses Is Expected To Begin In Fall 2025

JMP Securities analyst David Scharf reiterates OneMain Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMF#NYSE">OMF</a>) with a Market Outperform and maintains $65 price target.

Reiteration

JMP Securities Reiterates Market Outperform on OneMain Holdings, Maintains $65 Price Target

Smith & Nephew shares are trading higher after the company announced an exclusive private label distribution agreement with Nuo Therapeutics.

Barclays analyst Brandt Montour maintains Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) with a Overweight and lowers the price target from $233 to $232.

Barclays Maintains Overweight on Hilton Worldwide Holdings, Lowers Price Target to $232

Snap Inc's sharp stock fall Wednesday following its first-quarter <a href="https://www.benzinga.com/general/social-media/25/04/45084721/snap-hits-900-million-users-beats-q1-estimates-but-stock-slides-on-uncertainty">earnings</a> is weighing on peer platforms like Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>), highlighting investor unease with digital ad-reliant social media companies. Reddit shares are trading lower by some 7.6% to $112.84 during Wednesday&#8217;s session.
Major indexes also declined Wednesday following news of a <a href="https://www.benzinga.com/economics/macro-economic-events/25/04/45100047/recession-odds-spike-wall-street-tumbles-as-q1-gdp-surprisingly-contracts-be-patient-trump-responds">first-quarter GDP contraction</a>, likely adding pressure to Reddit shares as well.
What To Know: Snap beat expectations on revenue and adjusted earnings, reporting $1.36 billion in revenue and a narrower loss of 8 cents per share.&nbsp;
However, the company declined to provide <a href="https://www.benzinga.com/pressreleases/25/04/b45083101/snap-inc-announces-first-quarter-2025-financial-results">second-quarter guidance</a>, citing macroeconomic uncertainty and unpredictable ad demand—despite growing its daily active users to 460 million and reporting a 60% increase in active advertisers.
Read Also: <a href="https://www.benzinga.com/25/04/45098912/caterpillar-faces-lower-q1-results-but-projects-flat-sales-in-2025-or-slight-decline-with-tariff-headwinds">Caterpillar Warns Of $250 Million To $350 Million Tariff Hit After Q1 Profit Miss</a>
This caution casts a shadow over Reddit, which recently went public and derives the vast majority of its revenue from advertising. While Snap has a more mature and scaled platform, Reddit shares its reliance on advertising and youth-oriented audiences, but lacks Snap's reach and monetization track record.&nbsp;
Investors are particularly sensitive to signals of instability in ad markets, and Snap's hesitation to forecast future performance suggests ongoing volatility.
Reddit, still in the early stages of scaling its ad platform and proving sustainable growth, is exposed to the same macro headwinds—without the cushion of a decade-long operational history or a diversified revenue base. Snap's earnings, while strong in parts, underline the fragility of the ad market, dragging sentiment around Reddit down with it.
Read Also: <a href="https://www.benzinga.com/25/04/45078148/6-stocks-showing-momentum-as-the-market-rebounds">6 Stocks Showing Momentum As The Market Rebounds</a>
<h2 class="wp-block-heading">How To Buy RDDT Stock</h2>
By now you're likely curious about how to participate in the market for Reddit &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Reddit, which is trading at $112.84 as of publishing time, $100 would buy you about 0.89 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RDDT has a 52-week high of $230.41 and a 52-week low of $44.60.

RDDT

Reddit (RDDT) Stock Slumps After Snap Earnings: What's Going On?

Barclays analyst Anthony Powell maintains First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) with a Equal-Weight and lowers the price target from $56 to $52.

Barclays Maintains Equal-Weight on First Industrial Realty, Lowers Price Target to $52

Press Releases

General

Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma

Health Care

Legal

Humacyte Announces Issuance of U.S. Patent Covering Manufacturing of Symvess™ and Other Bioengineered Tissues

Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025

Trestle Bio Announces Research Collaboration with Humacyte

Humacyte Announces Publication of the Budget Impact Model (BIM) for Symvess™ (acellular tissue engineered vessel-tyod) in the Journal of Medical Economics

Financing

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

Comments

Humacyte

Humacyte (HUMA) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌